Advisory Committee on Immunization Practices (ACIP), 51612-51613 [E9-24157]
Download as PDF
<![CDATA[
51612
Federal Register / Vol. 74, No. 193 / Wednesday, October 7, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
November 4, 2009, 8 a.m. to November
5, 2009, 5 p.m., Bethesda North Marriott
Hotel & Conference Center, Montgomery
County Conference Center Facility, 5701
Marinelli Road, North Bethesda, MD
20852 which was published in the
Federal Register on August 21, 2009,
74FR42315.
This Federal Register Notice is being
amended to reflect a change in the name
of the committee to ‘‘Application of
Emerging Technologies and
Biospecimen Science for Cancer
Research’’ and not as otherwise stated.
The meeting is closed to the public.
Dated: October 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–24172 Filed 10–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
erowe on DSK5CLS3C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Elderly
Rodent Colony.
Date: October 27, 2009.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute On Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
VerDate Nov<24>2008
15:25 Oct 06, 2009
Jkt 220001
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Aging Special Emphasis Panel; NIA
Institutional Research Training Grants—T32/
T35.
Date: November 12–13, 2009.
Time: November 12, 2009, 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Alfonso R. Latoni, PhD,
Deputy Chief, Scientific Review Branch,
National Institute on Aging, 7201 Wisconsin
Avenue, Suite 2C218, Bethesda, MD 20892,
301–402–7702, latonia@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Boston Health
Study.
Date: November 16, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C218, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Alfonso R. Latoni, PhD,
Deputy Chief, Scientific Review Branch,
National Institute on Aging, 7201 Wisconsin
Avenue, Suite 2C218, Bethesda, MD 20892,
301–402–7702, latonia@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: October 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–24169 Filed 10–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group Clinical Trials
Review Committee.
Date: October 26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Keary A Cope, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7190,
Bethesda, MD 20892–7924, 301–435–2222,
copeka@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–24167 Filed 10–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 8 a.m.–5:30 p.m., October
21, 2009; 8 a.m.–4:30 p.m., October 22, 2009.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters to be Discussed: The agenda will
include discussions on: Human
E:\FR\FM\07OCN1.SGM
07OCN1
Federal Register / Vol. 74, No. 193 / Wednesday, October 7, 2009 / Notices
Papillomavirus (HPV) Vaccines; 2010
Childhood & Adolescent Immunization
Schedule; 2010 Adult Immunization
Schedule; General Recommendations;
Respiratory Syncytial Virus; Meningococcal
Vaccines; Yellow Fever Vaccine; Rotavirus
Vaccines; 13–Valent Pneumococcal
Conjugate Vaccine; and Influenza Vaccines.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for Immunization
and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., (E–05), Atlanta, Georgia 30333,
telephone 404/639–8836, fax 404/639–8905.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the CDC
and ATSDR.
Dated: September 30, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–24157 Filed 10–6–09; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
erowe on DSK5CLS3C1PROD with NOTICES
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
October 16, 2009, 8 a.m. to October 16,
2009, 5 p.m., Grand Hyatt Seattle, 721
Pine Street, Seattle, WA 98101 which
was published in the Federal Register
on September 22, 2009, 74 FR 48269–
48273.
The time of the meeting on October
16, 2009 has been changed to 7:30 a.m.
to 1:30 p.m. The meeting date and
location remain the same. The meeting
is closed to the public.
Dated: September 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–24032 Filed 10–6–09; 8:45 am]
BILLING CODE 4140–01–M
VerDate Nov<24>2008
15:25 Oct 06, 2009
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cardiac Ion
Channels.
Date: October 14, 2009.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Melrose Hotel, 2430
Pennsylvania Avenue, NW., Washington, DC
20037.
Contact Person: Rajiv Kumar, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7802, Bethesda, MD 20892, 301–435–
1212, kumarra@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immune Mechanisms.
Date: October 28–29, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Jian Wang, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4095D, MSC 7812, Bethesda,
MD 20892, (301) 435–2778,
wangjia@csr.niIigov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Grant Applications: Non-HIV
Microbial Vaccine Development.
Date: October 29–30, 2009.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: State Plaza Hotel, 2117 E Street,
NW., Washington, DC 20037.
Contact Person: Stephen M. Nigida, PhD,
Scientific Review Officer, Center for
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
51613
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212,
MSC 7812, Bethesda, MD 20892, 301–435–
1222, nigidas©csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Behavioral
Genetics and Epidemiology Member
Applications.
Date: October 29–30, 2009.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Suzanne Ryan, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
Bethesda, MD 20892, (301) 435–1712,
ryansj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Immunobiology of Microbial Vaccines:
Member Conflicts.
Date: October 30, 2009.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: State Plaza Hotel, 2117 E Street,
NW., Washington, DC 20037.
Contact Person: Stephen M. Nigida, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212,
MSC 7812, Bethesda, MD 20892, 301–435–
1222, nigidas@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–24034 Filed 10–6–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 74, Number 193 (Wednesday, October 7, 2009)]
[Notices]
[Pages 51612-51613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-24157]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 8 a.m.-5:30 p.m., October 21, 2009; 8 a.m.-4:30
p.m., October 22, 2009.
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters to be Discussed: The agenda will include discussions on:
Human
[[Page 51613]]
Papillomavirus (HPV) Vaccines; 2010 Childhood & Adolescent
Immunization Schedule; 2010 Adult Immunization Schedule; General
Recommendations; Respiratory Syncytial Virus; Meningococcal
Vaccines; Yellow Fever Vaccine; Rotavirus Vaccines; 13-Valent
Pneumococcal Conjugate Vaccine; and Influenza Vaccines. Agenda items
are subject to change as priorities dictate.
Contact Person for More Information: Antonette Hill,
Immunization Services Division, National Center for Immunization and
Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta,
Georgia 30333, telephone 404/639-8836, fax 404/639-8905.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the CDC and ATSDR.
Dated: September 30, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-24157 Filed 10-6-09; 8:45 am]
BILLING CODE 4160-18-P
